stella
beta
Switch to Dolutegravir Plus Lamivudine Dual-Therapy in Transgender Women Living With HIV on Virologically Suppressive Antiretroviral Therapy (TRANS-SWITCH) — Stella
Recruiting
Back to HIV trials
Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.
Trial locations
(1 site)
Argentina
Hospital General de Agudos Dr. Juan A. Fernández, Infectious Diseases Division, Buenos Aires, Buenos Aires F.D.
View full record on ClinicalTrials.gov